Literature DB >> 20573825

Characterization of the host immune response in human Ganglia after herpes zoster.

Kavitha Gowrishankar1, Megan Steain, Anthony L Cunningham, Michael Rodriguez, Peter Blumbergs, Barry Slobedman, Allison Abendroth.   

Abstract

Varicella-zoster virus (VZV) causes varicella (chicken pox) and establishes latency in ganglia, from where it reactivates to cause herpes zoster (shingles), which is often followed by postherpetic neuralgia (PHN), causing severe neuropathic pain that can last for years after the rash. Despite the major impact of herpes zoster and PHN on quality of life, the nature and kinetics of the virus-immune cell interactions that result in ganglion damage have not been defined. We obtained rare material consisting of seven sensory ganglia from three donors who had suffered from herpes zoster between 1 and 4.5 months before death but who had not died from herpes zoster. We performed immunostaining to investigate the site of VZV infection and to phenotype immune cells in these ganglia. VZV antigen was localized almost exclusively to neurons, and in at least one case it persisted long after resolution of the rash. The large immune infiltrate consisted of noncytolytic CD8(+) T cells, with lesser numbers of CD4(+) T cells, B cells, NK cells, and macrophages and no dendritic cells. VZV antigen-positive neurons did not express detectable major histocompatibility complex (MHC) class I, nor did CD8(+) T cells surround infected neurons, suggesting that mechanisms of immune control may not be dependent on direct contact. This is the first report defining the nature of the immune response in ganglia following herpes zoster and provides evidence for persistence of non-latency-associated viral antigen and inflammation beyond rash resolution.

Entities:  

Mesh:

Year:  2010        PMID: 20573825      PMCID: PMC2919016          DOI: 10.1128/JVI.01020-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  The prognosis with postherpetic neuralgia.

Authors:  Peter N C Watson; Verna R Watt; Mary Chipman; Nicholas Birkett; Ramon J Evans
Journal:  Pain       Date:  1991-08       Impact factor: 6.961

2.  Viral persistence in neurons explained by lack of major histocompatibility class I expression.

Authors:  E Joly; L Mucke; M B Oldstone
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

3.  Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens.

Authors:  J I Cohen
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

4.  Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects.

Authors:  Bernd Leinweber; Helmut Kerl; Lorenzo Cerroni
Journal:  Am J Surg Pathol       Date:  2006-01       Impact factor: 6.394

5.  Post-herpetic neuralgia: further post-mortem studies of cases with and without pain.

Authors:  C P N Watson; J H Deck; C Morshead; D Van der Kooy; R J Evans
Journal:  Pain       Date:  1991-02       Impact factor: 6.961

6.  Absence of circulating natural killer and primed CD8+ cells in life-threatening varicella.

Authors:  Mireille T M Vossen; Maarten H Biezeveld; Menno D de Jong; Mi-Ran Gent; Paul A Baars; Ines A von Rosenstiel; René A W van Lier; Taco W Kuijpers
Journal:  J Infect Dis       Date:  2004-12-15       Impact factor: 5.226

7.  The role of CD4 and CD8 cytotoxic T lymphocytes in the formation of viral vesicles.

Authors:  S Morizane; D Suzuki; K Tsuji; T Oono; K Iwatsuki
Journal:  Br J Dermatol       Date:  2005-11       Impact factor: 9.302

Review 8.  Varicella zoster virus latency, neurological disease and experimental models: an update.

Authors:  Randall J Cohrs; Donald H Gilden; Ravi Mahalingam
Journal:  Front Biosci       Date:  2004-01-01

9.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

10.  Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors:  S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391

View more
  30 in total

1.  Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons.

Authors:  Leigh Zerboni; Raymond A Sobel; Michelle Lai; Richard Triglia; Megan Steain; Allison Abendroth; Ann Arvin
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.

Authors:  Nicole Arnold; Christine Meyer; Flora Engelmann; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2017-03-20       Impact factor: 2.643

3.  Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.

Authors:  Chelsea Gerada; Megan Steain; Tessa Mollie Campbell; Brian McSharry; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 4.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 5.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

6.  Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.

Authors:  Megan Steain; Jeremy P Sutherland; Michael Rodriguez; Anthony L Cunningham; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 7.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

Review 8.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

9.  Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.

Authors:  Megan Steain; Kavitha Gowrishankar; Michael Rodriguez; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 10.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.